Cargando…

Inositols and metabolic disorders: From farm to bedside

Inositol and its derivates are catching interest in metabolism since taking part in several physiological processes, including endocrine modulation. Through several mechanisms mostly mediated by insulin signaling, these compounds regulate the activities of several hormones and are essential in oocyt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caputo, M., Bona, E., Leone, I., Samà, M.T., Nuzzo, A., Ferrero, A., Aimaretti, G., Marzullo, P., Prodam, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Metabolic syndrome/PCOS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340869/ https://www.ncbi.nlm.nih.gov/pubmed/32670820 http://dx.doi.org/10.1016/j.jtcme.2020.03.005

Ejemplares similares

Weight change over five-year periods and number of components of the metabolic syndrome in a Dutch cohort
por: Bot, M., et al.
Publicado: (2010)

Obesity preventive function of novel edible mushroom, Basidiomycetes-X (Echigoshirayukidake): Manipulations of insulin resistance and lipid metabolism
por: Khatun, Mst Afifa, et al.
Publicado: (2020)

Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
por: Barber, Thomas M, et al.
Publicado: (2019)

The insulin signaling pathway is dysregulated in cumulus cells from obese, infertile women with polycystic ovarian syndrome with an absence of clinical insulin resistance
por: Chehin, Mauricio B., et al.
Publicado: (2020)

Relationship Between Blood Pressure Values, Depressive Symptoms, and Cardiovascular Outcomes in Patients With Cardiometabolic Disease
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2016)

The Source of Polycystic Ovarian Syndrome
por: Raperport, Claudia, et al.
Publicado: (2019)

PCOS and Hyperprolactinemia: what do we know in 2019?
por: Delcour, Clémence, et al.
Publicado: (2019)

Controversies in the diagnosis of polycystic ovary syndrome
por: Rao, Preetham, et al.
Publicado: (2020)

Fertility Treatment Options for Women With Polycystic Ovary Syndrome
por: Sawant, Shital, et al.
Publicado: (2019)

Characteristics of polycystic ovary syndrome throughout life
por: Louwers, Yvonne V., et al.
Publicado: (2020)

What is new in the landscape of insulin-sensitizing agents for polycystic ovary syndrome treatment
por: Romualdi, Daniela, et al.
Publicado: (2020)

Real-world evaluation of weekly subcutaneous treatment with semaglutide in a cohort of Italian diabetic patients
por: Marzullo, P., et al.
Publicado: (2022)

Discordant biochemical parameters of acromegaly remission do not influence the prevalence or aggressiveness of metabolic comorbidities: a single-center study
por: Romanisio, Martina, et al.
Publicado: (2023)

Circulating adipokines and metabolic setting in differentiated thyroid cancer
por: Mele, Chiara, et al.
Publicado: (2019)

Gestational Diabetes Mellitus: Clinical Characteristics and Perinatal Outcomes in a Multiethnic Population of North Italy
por: Caputo, M., et al.
Publicado: (2021)

Immunomodulatory Effects of Vitamin D in Thyroid Diseases
por: Mele, Chiara, et al.
Publicado: (2020)

Case Report: Liraglutide for Weight Management in Beckwith-Wiedemann Syndromic Obesity
por: Caputo, Marina, et al.
Publicado: (2021)

Bone Response to Weight Loss Following Bariatric Surgery
por: Mele, Chiara, et al.
Publicado: (2022)

Impact of metformin on the clinical and metabolic parameters of women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials
por: Abdalla, Mohammed Altigani, et al.
Publicado: (2022)

Epilepsy and TSC-Associated Neuropsychiatric Disorders
por: Capal, Jamie K.
Publicado: (2020)

Myo-inositol: its metabolism and potential implications for poultry nutrition—a review
por: Gonzalez-Uarquin, Fernando, et al.
Publicado: (2019)

Epidemiology of Locomotive Organ Disorders and Symptoms: An Estimation Using the Population-Based Cohorts in Japan
por: Yoshimura, Noriko, et al.
Publicado: (2016)

Neuroinflammation and Hypothalamo-Pituitary Dysfunction: Focus of Traumatic Brain Injury
por: Mele, Chiara, et al.
Publicado: (2021)

Inositol(s) from Bench to Bedside in Endocrinology and Gynecology
por: Unfer, Vittorio, et al.
Publicado: (2017)

Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome
por: McDonnell, Tara, et al.
Publicado: (2022)

Inositol and gradient phytase supplementation in broiler diets during a 6-week production period: 2. Effects on phytate degradation and inositol liberation in gizzard and ileal digesta contents
por: Kriseldi, R., et al.
Publicado: (2020)

Impacts of dietary calcium, phytate, and phytase on inositol hexakisphosphate degradation and inositol phosphate release in different segments of digestive tract of broilers
por: Li, W., et al.
Publicado: (2017)

Corrigendum to “Inositol(s) from Bench to Bedside in Endocrinology and Gynecology”
por: Unfer, Vittorio, et al.
Publicado: (2017)

Salivary Gland Mucosa‐Associated Lymphoid Tissue–Type Lymphoma From Sjögren’s Syndrome Patients in the Majority Express Rheumatoid Factors Affinity‐Selected for IgG
por: Bende, Richard J., et al.
Publicado: (2020)

Locomotive Syndrome: Operational Definition Based on a Questionnaire, and Exercise Interventions on Mobility Dysfunction in Elderly People
por: Akai, M, et al.
Publicado: (2016)

Patient burden of Sjögren’s: a comprehensive literature review revealing the range and heterogeneity of measures used in assessments of severity
por: Hammitt, Katherine M, et al.
Publicado: (2017)

Dysregulated long non-coding RNA in Sjögren’s disease impacts both interferon and adaptive immune responses
por: Joachims, Michelle L, et al.
Publicado: (2022)

Salivary gland secretome: a novel tool towards molecular stratification of patients with primary Sjögren’s syndrome and non-autoimmune sicca
por: Blokland, Sofie L M, et al.
Publicado: (2019)

Proteogenomic analysis of the autoreactive B cell repertoire in blood and tissues of patients with Sjögren’s syndrome
por: Broeren, Mathijs G A, et al.
Publicado: (2022)

Short- and long-term effects of erythropoietin treatment on endothelial progenitor cell levels in patients with cardiorenal syndrome
por: Jie, Kim E, et al.
Publicado: (2010)

Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren’s syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?
por: Blokland, Sofie L M, et al.
Publicado: (2019)

Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren’s syndrome
por: Verstappen, Gwenny M, et al.
Publicado: (2022)

Lysosome-associated membrane protein 3 misexpression in salivary glands induces a Sjögren’s syndrome-like phenotype in mice
por: Nakamura, Hiroyuki, et al.
Publicado: (2021)

Symptom‐Based Cluster Analysis Categorizes Sjögren's Disease Subtypes: An International Cohort Study Highlighting Disease Severity and Treatment Discordance
por: McCoy, Sara S., et al.
Publicado: (2022)

Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren’s syndrome that show potential to predict and monitor clinical response
por: Hamkour, Safae, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_emq1cf775etjpup5ntj8lihimq